Targeting Glycolysis as a New Approach to the Treatment of Epilepsy
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
Dietary Supplements
Phase Of Development
Preclinical
Sponsors and Collaborators
Baylor College of Medicine, Epilepsy Research Foundation, NIH-NINDS (NS039941)
Mechanism of Action
Mechanism Description
fructose-1,6-bisphosphate to inhibit glycolysis (shifts metabolism of glusose from glycolytic pathway to pentose phosphate pathway)
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2005
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
No presentations found. Published JNeuroscience,27(44):12007-12011, 2007
Location of Clinical Trials
Baylor College of Medicine
Clinical Trial link